BFA
NWBO

BlackRock Fund Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

BlackRock Fund Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,374
Closed -$4K – 4328
2016
Q3 		$4K Buy
7,374
+804
+12% +$368 ﹤0.01% 4124
2016
Q2 		$4K Sell
6,570
-1,346,742
-100% -$1.44M ﹤0.01% 4157
2016
Q1 		$1.98M Buy
1,353,312
+58,481
+5% +$115K ﹤0.01% 3083
2015
Q4 		$4.14M Buy
1,294,831
+67,024
+5% +$322K ﹤0.01% 2929
2015
Q3 		$7.67M Buy
1,227,807
+6,847
+0.6% +$64K ﹤0.01% 2532
2015
Q2 		$12.1M Buy
1,220,960
+20,909
+2% +$183K ﹤0.01% 2395
2015
Q1 		$8.84M Buy
1,200,051
+130,021
+12% +$875K ﹤0.01% 2507
2014
Q4 		$5.72M Buy
1,070,030
+214,493
+25% +$1.1M ﹤0.01% 2800
2014
Q3 		$4.3M Sell
855,537
-21,046
-2% -$129K ﹤0.01% 2839
2014
Q2 		$5.88M Buy
876,583
+789,219
+903% +$5.02M ﹤0.01% 2746
2014
Q1 		$633K Buy
87,364
+10,593
+14% +$62.8K ﹤0.01% 3230
2013
Q4 		$289K Buy
76,771
+16,498
+27% +$63.8K ﹤0.01% 3331
2013
Q3 		$203K Buy
60,273
+4,734
+9% +$16.5K ﹤0.01% 3381
2013
Q2 		$186K Buy
+55,539
New +$201K ﹤0.01% 3350

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

BlackRock Fund Advisors's NWBO Position: Q4 2016 in Review

BlackRock Fund Advisors sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 7,374 shares — an estimated $4K sold.

BlackRock Fund Advisors first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $12.1M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • BlackRock Fund Advisors reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 7,374 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $4K.
  • BlackRock Fund Advisors first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 14 quarters.
  • BlackRock Fund Advisors's Northwest Biotherapeutics, Inc. Common stock position peaked at $12.1M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.